Signaling Crosstalk between PPARγand BMP2 in Mesenchymal Stem Cells

Authors:

Abstract
Recent studies have revealed that PPARγ’s transactivation function is regulated by extracellular signals. In particular, cytokines and Wnt family proteins suppress the ligand-inducible transactivation function of PPARγand attenuate adipogenesis/osteoblastogenesis switching in mesenchymal stem cells (MSCs). For example, Wnt5a suppresses PPARγtranscriptional activity through the NLK/SETDB1/CHD7 pathway. Among these factors, BMP2 strongly induces bone formation, but the effect of BMP2 on PPARγfunction remains unclear. We examined the effect of BMP2 and PPARγin ST2 cells and found that PPARγactivation affected BMP2’s signaling pathway through epigenetic regulation. Although BMP2 did not interfere with PPARγ-mediated adipogenesis, BMP2 increased mRNA expression levels of PPARγtarget genes (such asFabp4andNr1h3) when cells were first treated with troglitazone (TRO). Moreover, PPARγactivation affected BMP2 through enhancement of histone activation markers (acetylated histone H3 and trimethylated Lys4 of histone H3) on theRunx2promoter. After TRO treatment for three hours, BMP2 enhanced the levels of active histone marks on the promoter of a PPARγtarget gene. These results suggest that the order of treatment with BMP2 and a PPARγligand is critical for adipogenesis and osteoblastogenesis switching in MSCs.
Funding Information
  • Japan Society for the Promotion of Science (23791622)

This publication has 33 references indexed in Scilit: